GALT
GALECTIN THERAPEUTICS INC
+0.05 (+1.36%)3.73USD45.3K成交股數376M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.1M | 2.2M | 1.9M | 2.6M | 3.3M | 6.5M | 7.6M | 9.8M | 8.1M | 8.2M | 7.7M | 7.4M |
| 銷售管理費用 | 1.8M | 1.8M | 1.4M | 1.6M | 1.4M | 1.4M | 1.5M | 1.5M | 1.6M | 1.3M | 1.4M | 1.6M |
| 營業利益 | −4.0M-14% | −4.1M-48% | −3.4M-63% | −4.2M-63% | −4.6M-52% | −7.9M-17% | −9.1M-1% | −11.3M+25% | −9.6M | −9.6M | −9.2M | −9.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −9.1M+21% | −5.0M-48% | −5.5M-51% | −8.2M-34% | −7.5M-35% | −9.6M-4% | −11.2M+8% | −12.4M+36% | −11.5M | −10.0M | −10.4M | −9.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.14+17% | -0.08-47% | -0.08-56% | -0.13-35% | -0.12-37% | -0.15-6% | -0.18-25% | -0.20+33% | -0.19 | -0.16 | -0.24 | -0.15 |
| 稀釋股數 | 65.9M | 65.8M | 63.9M | 64.2M | 63.4M | 63.2M | 62.3M | 62.2M | 62.0M | 60.2M | 59.7M | 59.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 13.3M | 14.1M | 17.7M | 11.5M | 13.8M | 7.4M | 27.1M | 25.6M | 23.6M | 25.7M | 20.4M | 18.0M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 14.8M | 15.8M | 19.5M | 12.9M | 15.6M | 9.5M | 29.0M | 27.7M | 25.9M | 28.2M | 22.2M | 20.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 152M | 146M | 146M | 136M | 133M | 122M | 121M | 110M | 97.0M | 88.4M | 73.0M | 71.2M |
| 股東權益 | −139M | −132M | −128M | −125M | −119M | −114M | −94.2M | −83.9M | −44.4M | −62.0M | −52.6M | −52.9M |
| 負債比 | 1,023.1% | 926.4% | 746.1% | 1,060.6% | 851.0% | 1,278.2% | 419.2% | 397.0% | 374.6% | 313.6% | 329.5% | 354.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.9M-50% | – | – | – | −7.7M | – | – | −12.1M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −30.8M | –% | -0.48 | – |
| FY2024 | – | – | −47.0M | –% | -0.76 | – |
| FY2023 | – | – | −41.1M | –% | -0.74 | – |
| FY2022 | – | – | −38.8M | –% | -0.65 | – |
| FY2021 | – | – | −30.5M | –% | -0.52 | – |
| FY2020 | – | – | −23.5M | –% | -0.41 | – |
| FY2019 | – | – | −13.3M | –% | -0.39 | – |
| FY2018 | – | – | −13.9M | –% | -0.38 | – |